FRANKLIN LAKES, N.J. (March 12, 2019) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement:
BD no longer manufactures or sells ventilators. In 2018, BD fully divested its Respiratory business to funds advised by Apax Partners. In 2016, the two companies announced BD’s respiratory business would be spun off as a joint venture, forming a separate company called Vyaire Medical. Additional information can be found in the announcements below from 2016 and 2018.
- Funds advised by Apax Partners to acquire remaining minority stake in Vyaire Medical from BD (March 19, 2018)
- BD and Apax Partners Announce Closing of Joint Venture to Launch Global Respiratory Business (Oct. 4, 2016)
- BD, Apax Partners to Form Joint Venture for Respiratory Solutions (March 8, 2016)
# # #
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com.